ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
20 announcements with these filters
Acutaas Chemicals Limited has announced the re-appointment of Ram Mohan Lokhande as Executive Director and Anita Bandyopadhyay as Non-Executive Independent Director for a 60-month term.
Acutaas Chemicals will acquire 100% of Enchem Ami Organics Private Limited for Rs. 1 Lakh, making it a wholly owned subsidiary.
Acutaas Chemicals will acquire 100% equity stake in step-down subsidiary Enchem Ami Organics for Rs. 1 Lakh, making it a direct wholly-owned subsidiary.
Acutaas Chemicals Limited conducted its 19th Annual General Meeting on September 24, 2026, where shareholders transacted various ordinary and special business items.
Acutaas Chemicals Limited has received a patent from the Indian Patent Office for a process to prepare 2,4-dimethylthiophenol. The company now holds 11 patents.
Acutaas Chemicals Limited inaugurated a new state-of-the-art Pilot Plant at Unit 1 in Sachin, Surat. The facility supports R&D for high potency active pharmaceutical ingredients.
Acutaas Chemicals Limited has set September 17, 2026, as the record date for its final dividend of Rs. 2.50 per share for FY 2025-26.
Acutaas Chemicals Limited has submitted its Business Responsibility and Sustainability Report for the financial year 2025-26. This filing complies with the SEBI LODR regulations.
Acutaas Chemicals Limited has submitted its Annual Report for the financial year 2025-26. The document contains comprehensive performance details, strategic updates, and statutory reports.
Acutaas Chemicals Limited has issued a notice for its 19th Annual General Meeting on September 24, 2026, to consider financial statements, director appointments, and related-party transaction limits.
Acutaas Chemicals' subsidiary, Indichem Inc., inaugurated its semiconductor materials manufacturing plant in South Korea. The new facility enhances the company's semiconductor supply chain capabilities.
Acutaas Chemicals approved a Rs. 212 Crore capital expenditure plan for a new manufacturing plant in Gujarat. The Board also announced the upcoming 19th AGM.
Acutaas Chemicals received approval for incentives under the Electronics Components Manufacturing Scheme. The company expects benefits of 25% on an eligible investment of ₹119.12 Crore.
Acutaas Chemicals Limited received MeitY approval for an incentive package under the Electronics Components Manufacturing Scheme. The company is expected to receive incentives up to 25% of Rs.119.12 Crore.
Acutaas Chemicals delivered a robust Q1 FY27 with 59.1% revenue growth, fueled by strong CDMO and Advanced Pharmaceutical Intermediates (API) performance.
Acutaas Chemicals delivered strong Q1 FY27 results with 59% YoY revenue growth. Management is focused on scaling high-margin Pharma Intermediates and CDMO segments while maintaining operational efficiencies.
Acutaas Chemicals reported Q1 FY27 revenue of ₹329.7 crore and PAT of ₹75 crore. Revenue grew 59.1% YoY with PAT margins at 22.7%.
Acutaas Chemicals Ltd reported revenue from operations of ₹329.7 Cr (+59.1% YoY) and net profit of ₹75 Cr (+70.5% YoY) for Q1 FY27.
Acutaas Chemicals approved its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. The board meeting concluded on July 24, 2026.
Acutaas Chemicals scheduled a board meeting for July 24, 2026. The board will consider the unaudited financial results for the June 30, 2026 quarter.